PDL BioPharma, Inc. (
) will begin trading ex-dividend on March 03, 2014. A cash dividend
payment of $0.15 per share is scheduled to be paid on March 12,
2014. Shareholders who purchased PDLI stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
marks the 16th quarter that PDLI has paid the same dividend. At the
current stock price of $8.82, the dividend yield is 6.8%.
The previous trading day's last sale of PDLI was $8.82,
representing a -13.57% decrease from the 52 week high of $10.21 and
a 29.33% increase over the 52 week low of $6.82.
PDLI is a part of the Health Care sector, which includes
companies such as Gilead Sciences, Inc. (
) and Amgen Inc. (
). PDLI's current earnings per share, an indicator of a company's
profitability, is $1.68. Zacks Investment Research reports PDLI's
forecasted earnings growth in 2013 as 21.77%, compared to an
industry average of 6.2%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to PDLI through an Exchange
Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:
- First Trust DJ Global Select Dividend (
- WisdomTree SmallCap Earnings Fund (
- WisdomTree Trust SmallCap Dividend Fund (
The top-performing ETF of this group is EES with an increase of
9.53% over the last 100 days. FGD has the highest percent weighting
of PDLI at 1.43%.